Albireo And Odevixibat In Orphan Pediatric Cholestatic Liver Diseases: Making Magnificent ProgressSeeking Alpha • 06/19/19
Albireo Pharma, Inc. (ALBO) CEO Ronald Cooper on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/09/19